These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6711309)
1. Analysis of the immune response to papain digestion products of tetanus toxin. Helting TB; Nau HH Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):59-63. PubMed ID: 6711309 [TBL] [Abstract][Full Text] [Related]
2. Transcutaneous delivery of tetanus toxin Hc fragment induces superior tetanus toxin neutralizing antibody response compared to tetanus toxoid. Johnston L; Mawas F; Tierney R; Qazi O; Fairweather N; Sesardic D Hum Vaccin; 2009 Apr; 5(4):230-6. PubMed ID: 18948742 [TBL] [Abstract][Full Text] [Related]
3. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids. Gupta RK; Siber GR Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950 [TBL] [Abstract][Full Text] [Related]
4. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines. Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677 [TBL] [Abstract][Full Text] [Related]
5. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets. Amuguni H; Lee S; Kerstein K; Brown D; Belitsky B; Herrmann J; Keusch G; Sonenshein A; Tzipori S Microbes Infect; 2012 May; 14(5):447-56. PubMed ID: 22198093 [TBL] [Abstract][Full Text] [Related]
6. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule. Matsuda M; Makinaga G; Hirai T Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against tetanus toxin and toxoid. Ahnert-Hilger G; Bizzini B; Goretzki K; Müller H; Völckers C; Habermann E Med Microbiol Immunol; 1983; 172(2):123-35. PubMed ID: 6193402 [TBL] [Abstract][Full Text] [Related]
8. Immunity to tetanus: tetanus antitoxin and anti-BIIb in human sera. German-Fattal M; Bizzini B; German A J Biol Stand; 1987 Jul; 15(3):223-30. PubMed ID: 3611114 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay. Gupta RK; Siber GR Biologicals; 1994 Sep; 22(3):215-9. PubMed ID: 7811454 [TBL] [Abstract][Full Text] [Related]
10. Active immunization against tetanus in guinea-pigs. An attempt to evaluate "rapid immunization" with tetanus vaccine. Ullberg-Olsson K Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):166-72. PubMed ID: 134536 [TBL] [Abstract][Full Text] [Related]
11. Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin. Porter DC; Wang J; Moldoveanu Z; McPherson S; Morrow CD Vaccine; 1997 Feb; 15(3):257-64. PubMed ID: 9139483 [TBL] [Abstract][Full Text] [Related]
12. Enzymatic fragmentation of tetanus toxin. Identification and characterization of an atoxic, immunogenic fragment. Robinson JP; Chen HC; Hash JH; Puett D Mol Cell Biochem; 1978 Oct; 21(1):23-31. PubMed ID: 104144 [TBL] [Abstract][Full Text] [Related]
13. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments. Helting TB; Zwisler O J Biol Chem; 1977 Jan; 252(1):187-93. PubMed ID: 401808 [TBL] [Abstract][Full Text] [Related]
14. The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid. Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG Biologicals; 1991 Jan; 19(1):23-9. PubMed ID: 2049173 [TBL] [Abstract][Full Text] [Related]
15. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 1. Systems for the detection of in vitro synthetized specific immunoglobulins. Strategies of test development]. Kiessig ST; Jahn S; Porstmann T; von Baehr R Allerg Immunol (Leipz); 1987; 33(2):79-87. PubMed ID: 2959129 [TBL] [Abstract][Full Text] [Related]
16. Quantitation of commercial equine tetanus antitoxin by competitive enzyme-linked immunosorbent assay. Kolbe DR; Clough NE FEMS Immunol Med Microbiol; 1999 Jul; 24(3):313-7. PubMed ID: 10397316 [TBL] [Abstract][Full Text] [Related]
17. Relation between protective potency and specificity of antibodies in sera of tetanus immunized individuals. German-Fattal M; German A; Bizzini B Eur J Epidemiol; 1987 Jun; 3(2):119-22. PubMed ID: 3301392 [TBL] [Abstract][Full Text] [Related]
19. Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case. Saikh KU; Sesno J; Brandler P; Ulrich RG Vaccine; 1998; 16(9-10):1029-38. PubMed ID: 9682355 [TBL] [Abstract][Full Text] [Related]
20. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Grangette C; Müller-Alouf H; Geoffroy M; Goudercourt D; Turneer M; Mercenier A Vaccine; 2002 Sep; 20(27-28):3304-9. PubMed ID: 12213400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]